Core Scientific, Inc. (CORZ)
NASDAQ: CORZ · Real-Time Price · USD
11.76
+0.38 (3.34%)
At close: Nov 6, 2026, 4:00 PM EST
11.75
-0.01 (-0.09%)
After-hours: Nov 6, 2026, 7:58 PM EST
Core Scientific Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 486.01 | 89.81 | 101.93 | 112.07 | 242.52 | 327.56 |
Other Revenue | 106.07 | 229.21 | 408.74 | 390.33 | 397.8 | 216.93 |
| 592.07 | 319.02 | 510.67 | 502.4 | 640.31 | 544.48 | |
Revenue Growth | 77.17% | -37.53% | 1.65% | -21.54% | 17.60% | 802.66% |
Cost of Revenue | 331.21 | 264.43 | 376.99 | 378.94 | 631.91 | 305.62 |
Gross Profit | 260.87 | 54.59 | 133.68 | 123.46 | 8.4 | 238.86 |
Selling, General & Admin | 214.42 | 199.29 | 131.13 | 108.11 | 223.71 | 64.55 |
Research & Development | - | - | - | - | 26.96 | 7.67 |
Other Operating Expenses | 58.33 | 31.6 | 3.81 | 4.43 | 187.02 | 32.39 |
Operating Expenses | 273.03 | 230.89 | 134.93 | 112.54 | 437.69 | 104.61 |
Operating Income | -12.17 | -176.3 | -1.25 | 10.92 | -429.29 | 134.25 |
Interest Expense | -88.55 | - | -37.07 | -86.24 | -96.83 | -44.35 |
Interest & Investment Income | 23.9 | 3.28 | - | - | - | - |
Currency Exchange Gain (Loss) | - | - | - | - | -28.03 | -0.12 |
Other Non Operating Income (Expenses) | 279.17 | -33.1 | -1,367 | 2.53 | 42.2 | -0 |
EBT Excluding Unusual Items | 202.35 | -206.12 | -1,405 | -72.79 | -511.94 | 89.77 |
Merger & Restructuring Charges | 0.7 | - | - | - | -6.8 | - |
Impairment of Goodwill | - | - | - | - | -1,055 | - |
Gain (Loss) on Sale of Assets | -46.47 | -9.68 | -4.21 | -1.96 | - | - |
Asset Writedown | -277.85 | -11.36 | -122.87 | - | -590.74 | - |
Legal Settlements | 4.31 | -10.69 | -2.07 | - | - | -2.64 |
Other Unusual Items | -95.36 | -50.18 | 97.22 | -171.06 | 0.77 | -24.06 |
Pretax Income | -212.31 | -288.03 | -1,437 | -245.8 | -2,163 | 63.08 |
Income Tax Expense | -103.9 | 0.58 | 0.86 | 0.68 | -17.09 | 15.76 |
Net Income | -108.41 | -288.62 | -1,438 | -246.49 | -2,146 | 47.31 |
Preferred Dividends & Other Adjustments | 2.73 | -7.88 | -192.59 | - | - | - |
Net Income to Common | -111.14 | -280.74 | -1,245 | -246.49 | -2,146 | 47.31 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 324 | 318 | 256 | 380 | 341 | 207 |
Shares Outstanding (Diluted) | 324 | 318 | 256 | 380 | 341 | 233 |
Shares Change | 6.57% | 24.33% | -32.65% | 11.51% | 46.01% | 48.03% |
EPS (Basic) | -0.34 | -0.88 | -4.87 | -0.65 | -6.30 | 0.23 |
EPS (Diluted) | -0.35 | -0.88 | -4.87 | -0.65 | -6.30 | 0.20 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1,997 | -450.75 | -52.07 | 48.95 | -396.47 | -56.74 |
Free Cash Flow Per Share | -6.16 | -1.42 | -0.20 | 0.13 | -1.16 | -0.24 |
Gross Margin | 44.06% | 17.11% | 26.18% | 24.57% | 1.31% | 43.87% |
Operating Margin | -2.05% | -55.26% | -0.24% | 2.17% | -67.04% | 24.66% |
Profit Margin | -18.77% | -88.00% | -243.85% | -49.06% | -335.20% | 8.69% |
Free Cash Flow Margin | -337.35% | -141.29% | -10.20% | 9.74% | -61.92% | -10.42% |
EBITDA | 52.06 | -107.39 | 111.95 | 106.92 | -204.03 | 167.61 |
EBITDA Margin | 8.79% | -33.66% | 21.92% | 21.28% | -31.86% | 30.78% |
D&A For EBITDA | 64.23 | 68.91 | 113.21 | 96 | 225.26 | 33.36 |
EBIT | -12.17 | -176.3 | -1.25 | 10.92 | -429.29 | 134.25 |
EBIT Margin | -2.05% | -55.26% | -0.24% | 2.17% | -67.04% | 24.66% |
Effective Tax Rate | - | - | - | - | - | 24.99% |
Revenue as Reported | 592.07 | 319.02 | 510.67 | 502.4 | 640.31 | 544.48 |